Another disappointing quarter for AstraZeneca, shares drop 2%

Another disappointing quarter for AstraZeneca, shares drop 2%

Source: 
GoinPharma
snippet: 

UK-based pharmaceutical group AstraZeneca today announced its Q1 2018 results, before trading started in Europe. Investors did not approve the performance and AstraZeneca’s shares soon declined 2.3% as trading started.